ページの作成:「<br> Dapagliflozin is already authorised in the European Union as Forxiga and Edistride1 for the treatment of patients with type 2 diabetes. The CHMP opinion will now be…」
(ページの作成:「<br> Dapagliflozin is already authorised in the European Union as Forxiga and Edistride1 for the treatment of patients with type 2 diabetes. The CHMP opinion will now be…」)